Alterations in cholesterol absorption/synthesis markers characterize Framingham Offspring Study participants with CHD[S]

Data is limited on measures influencing cholesterol homeostasis in subjects at high risk of developing cardiovascular disease (CVD) relative to established risk factors. To address this, we quantified circulating indicators of cholesterol homeostasis (plasma phytosterols and cholesterol precursor co...

Full description

Bibliographic Details
Main Authors: Nirupa R. Matthan, Michael Pencina, Jane M. LaRocque, Paul F. Jacques, Ralph B. D'Agostino, Ernst J. Schaefer, Alice H. Lichtenstein
Format: Article
Language:English
Published: Elsevier 2009-09-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520307458
_version_ 1818601014012411904
author Nirupa R. Matthan
Michael Pencina
Jane M. LaRocque
Paul F. Jacques
Ralph B. D'Agostino
Ernst J. Schaefer
Alice H. Lichtenstein
author_facet Nirupa R. Matthan
Michael Pencina
Jane M. LaRocque
Paul F. Jacques
Ralph B. D'Agostino
Ernst J. Schaefer
Alice H. Lichtenstein
author_sort Nirupa R. Matthan
collection DOAJ
description Data is limited on measures influencing cholesterol homeostasis in subjects at high risk of developing cardiovascular disease (CVD) relative to established risk factors. To address this, we quantified circulating indicators of cholesterol homeostasis (plasma phytosterols and cholesterol precursor concentrations as surrogate measures of cholesterol absorption and synthesis, respectively) in Framingham Offspring Study Cycle-6 participants diagnosed with established CVD and/or ≥50% carotid stenosis not taking lipid lowering medication (cases, N = 155) and matched controls (N = 414). Cases and controls had similar plasma LDL-cholesterol; HDL-cholesterol was significantly lower in males, while triglyceride concentrations were significantly higher in female cases relative to their respective controls. Cholesterol absorption markers were significantly higher (229 ± 7 vs. 196 ± 4, 169 ± 6 vs. 149 ± 3 and 144 ± 5 vs. 135 ± 3 for campesterol, sitosterol, and cholestanol, respectively), whereas cholesterol synthesis markers were significantly lower (116 ± 4 vs. 138 ± 3, 73 ± 3 vs. 75 ± 2 for lathosterol and desmosterol, respectively) in cases compared with controls, irrespective of sex. After controlling for standard risk factors, campesterol (2.47 [1.71-3.56]; P < 0.0001), sitosterol (1.86 [1.38-2.50]; P < 0.0001), cholestanol (1.57 [1.09-2.27]; P = 0.02), desmosterol (0.59 [0.42-0.84]; P = 0.003), and lathosterol (0.58 [0.43-0.77]; P = 0.0002) were significantly associated with CVD (odds ratio [95% confidence interval]). These data suggest that impaired cholesterol homeostasis, reflected by lower synthesis and higher absorption marker concentrations, are highly significant independent predictors of prevalent CVD in this study population.
first_indexed 2024-12-16T12:44:38Z
format Article
id doaj.art-b1930793a91d4730a497a9cf442c767f
institution Directory Open Access Journal
issn 0022-2275
language English
last_indexed 2024-12-16T12:44:38Z
publishDate 2009-09-01
publisher Elsevier
record_format Article
series Journal of Lipid Research
spelling doaj.art-b1930793a91d4730a497a9cf442c767f2022-12-21T22:31:19ZengElsevierJournal of Lipid Research0022-22752009-09-0150919271935Alterations in cholesterol absorption/synthesis markers characterize Framingham Offspring Study participants with CHD[S]Nirupa R. Matthan0Michael Pencina1Jane M. LaRocque2Paul F. Jacques3Ralph B. D'Agostino4Ernst J. Schaefer5Alice H. Lichtenstein6To whom correspondence should be addressed.; Cardiovascular Nutrition, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston MAStatistics and Consulting Unit, Boston University, Boston MACardiovascular Nutrition, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston MANutritional Epidemiology, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston MAStatistics and Consulting Unit, Boston University, Boston MALipid Metabolism Laboratories, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston MACardiovascular Nutrition, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston MAData is limited on measures influencing cholesterol homeostasis in subjects at high risk of developing cardiovascular disease (CVD) relative to established risk factors. To address this, we quantified circulating indicators of cholesterol homeostasis (plasma phytosterols and cholesterol precursor concentrations as surrogate measures of cholesterol absorption and synthesis, respectively) in Framingham Offspring Study Cycle-6 participants diagnosed with established CVD and/or ≥50% carotid stenosis not taking lipid lowering medication (cases, N = 155) and matched controls (N = 414). Cases and controls had similar plasma LDL-cholesterol; HDL-cholesterol was significantly lower in males, while triglyceride concentrations were significantly higher in female cases relative to their respective controls. Cholesterol absorption markers were significantly higher (229 ± 7 vs. 196 ± 4, 169 ± 6 vs. 149 ± 3 and 144 ± 5 vs. 135 ± 3 for campesterol, sitosterol, and cholestanol, respectively), whereas cholesterol synthesis markers were significantly lower (116 ± 4 vs. 138 ± 3, 73 ± 3 vs. 75 ± 2 for lathosterol and desmosterol, respectively) in cases compared with controls, irrespective of sex. After controlling for standard risk factors, campesterol (2.47 [1.71-3.56]; P < 0.0001), sitosterol (1.86 [1.38-2.50]; P < 0.0001), cholestanol (1.57 [1.09-2.27]; P = 0.02), desmosterol (0.59 [0.42-0.84]; P = 0.003), and lathosterol (0.58 [0.43-0.77]; P = 0.0002) were significantly associated with CVD (odds ratio [95% confidence interval]). These data suggest that impaired cholesterol homeostasis, reflected by lower synthesis and higher absorption marker concentrations, are highly significant independent predictors of prevalent CVD in this study population.http://www.sciencedirect.com/science/article/pii/S0022227520307458lipidslipoproteinslathosteroldesmosterolphytosterolscampesterol
spellingShingle Nirupa R. Matthan
Michael Pencina
Jane M. LaRocque
Paul F. Jacques
Ralph B. D'Agostino
Ernst J. Schaefer
Alice H. Lichtenstein
Alterations in cholesterol absorption/synthesis markers characterize Framingham Offspring Study participants with CHD[S]
Journal of Lipid Research
lipids
lipoproteins
lathosterol
desmosterol
phytosterols
campesterol
title Alterations in cholesterol absorption/synthesis markers characterize Framingham Offspring Study participants with CHD[S]
title_full Alterations in cholesterol absorption/synthesis markers characterize Framingham Offspring Study participants with CHD[S]
title_fullStr Alterations in cholesterol absorption/synthesis markers characterize Framingham Offspring Study participants with CHD[S]
title_full_unstemmed Alterations in cholesterol absorption/synthesis markers characterize Framingham Offspring Study participants with CHD[S]
title_short Alterations in cholesterol absorption/synthesis markers characterize Framingham Offspring Study participants with CHD[S]
title_sort alterations in cholesterol absorption synthesis markers characterize framingham offspring study participants with chd s
topic lipids
lipoproteins
lathosterol
desmosterol
phytosterols
campesterol
url http://www.sciencedirect.com/science/article/pii/S0022227520307458
work_keys_str_mv AT niruparmatthan alterationsincholesterolabsorptionsynthesismarkerscharacterizeframinghamoffspringstudyparticipantswithchds
AT michaelpencina alterationsincholesterolabsorptionsynthesismarkerscharacterizeframinghamoffspringstudyparticipantswithchds
AT janemlarocque alterationsincholesterolabsorptionsynthesismarkerscharacterizeframinghamoffspringstudyparticipantswithchds
AT paulfjacques alterationsincholesterolabsorptionsynthesismarkerscharacterizeframinghamoffspringstudyparticipantswithchds
AT ralphbdagostino alterationsincholesterolabsorptionsynthesismarkerscharacterizeframinghamoffspringstudyparticipantswithchds
AT ernstjschaefer alterationsincholesterolabsorptionsynthesismarkerscharacterizeframinghamoffspringstudyparticipantswithchds
AT alicehlichtenstein alterationsincholesterolabsorptionsynthesismarkerscharacterizeframinghamoffspringstudyparticipantswithchds